(Update) D-skate hockey is a weeklong elite program in Milton for kids living with type 1 diabetes. Some very special guests were on hand today including NHL player Cory Conacher, retired NHL player Nick Boynton and Olympic rower Chris Jarvis. The camp has a lot of energy, it's the second year and this time out attendance has tripled with 61 rambunctious and ambitious kids. Hey - it's not hockey without a little bit of rough housing, just like the pros. During the camp parents and young athletes learn from medical experts, coaches and sport stars how to manage their diabetes. Alyssa Coulter, living with diabetes: "There's not just one way to manage diabetes -- not just two ways. I've heard of 50 different ways since the last two years I've been here." Parents sometimes think diabetes means their child can't participate in sports or ever ... Read more
Endocrinology | A combination of sitagliptin and lansoprazole did not halt the destruction of beta-cell function in patients recently-diagnosed with type 1 diabetes, according to research published in The Lancet Diabetes & Endocrinology. “One half of the group taking active sitagliptin and lansoprazole failed to increase the hormones on which our hypothesis was based: glucagon-like peptide-1 and
A collaborative group from Boston University and Massachusetts General Hospital is working together to make automated blood glucose control a reality, and they have announced their results from the Bionic Pancreas study. Scott, who is also a 20 year+ Type 1 Diabetic on an insulin pump, sits down with Dr. Steven Jon Russell, MD, PhD to talk about this project and it's ramifications.
There are many different ways of dealing with the daunting feeling of being diagnosed with a consuming chronic illness like diabetes. For Mary Rooney, a fellow type 1 diagnosed as an adult in March 2011, getting involved in the research side was one of the best diabetes decisions she made. While the 30-something (who happens to…
The world-renowned diabetes researcher who announced his move last month from the University of Pittsburgh School of Medicine to the Allegheny Health Network has not taken all 19 Pitt researchers with him, as originally announced. AHN said last month Massimo Trucco, the pediatric immunologist formerly based at Children’s Hospital of UPMC of Pittsburgh and working to cure Type 1 diabetes, would move to AHN to lead its newly created Institute for Cellular Therapeutics. Alejandro Soto-Gutierrez, a Pitt assistant professor of pathology, and his research team of four transplant surgeons, a biologist and a pathologist, decided against the move. “We did not feel that it was a good fit for our research.” His focus is development of entire replacement organs. Dr. Trucco is preparing to begin Phase